Tumor necrosis after preventive embolization of large renal angiomyolipomas. 2015

M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
Service d'imagerie néphro-urologique et ORL, université Lille, hôpital Claude-Huriez, CHRU de Lille, 1, rue Michel-Polonovski, 59037 Lille cedex, France.

OBJECTIVE The purpose of this study was to retrospectively evaluate tumor necrosis following preventive embolization in patients with renal angiomyolipoma (RAML) at high risk of bleeding. METHODS Arterial embolization was performed in 24 patients (22 women, 2 men; mean age, 43±13 years) with a total of 30 RAMLs (mean volume, 137 cm(3)±163) between 1996 and 2012. Two sub-groups of patients were identified and further compared based on the presence or not of necrosis following arterial embolization. RESULTS The technical and clinical success rates of arterial embolization of RAMLs were 97% and 87%, respectively. The mean initial volume of RAMLs differed between the two sub-groups with 331 cm(3) in the group with tumor necrosis and 88 cm(3) in the group without tumor necrosis (P=0.0047). High-fat content RAMLs were predominantly observed in the necrosis group and the mean volume reduction observed for high-fat RAMLs was 65% whereas it was 36% for low-fat content RAMLs. The six patients who developed RAML necrosis had arterial embolization using microspheres (one patient with microspheres alone and five with a combination of microspheres and metallic coils). All necrotic RAMLs displayed arterial dysplasia. CONCLUSIONS The risk of tumor necrosis is higher for larger RAMLs. The role of distal arterial embolization with microspheres in tumor necrosis in RAML is suggested by the results of our study but could not be definitely demonstrated statistically due to the limited sample size.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
October 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
September 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
December 2006, Journal de radiologie,
M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
April 2023, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
June 2010, Cardiovascular and interventional radiology,
M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
January 1984, Urologic radiology,
M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
August 2014, European radiology,
M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
January 2006, International urology and nephrology,
M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
January 2010, Journal of vascular and interventional radiology : JVIR,
M El Rafei, and B Renard, and P Puech, and P Devos, and V Gaillard, and L Lemaître
April 2019, The Journal of international medical research,
Copied contents to your clipboard!